英国诺福克地区尿路致病性大肠埃希菌的种群结构与抗菌药物敏感性
该研究收集2021年8月至2022年1月诺福克与诺里奇大学医院临床微生物实验室的199株尿路感染大肠埃希菌,行全基因组测序。菌株含70个ST型,8个谱系占56.7%;初筛6.5%为多重耐药,医院来源对氨苄西林耐药率52.1%、对甲氧苄啶耐药率36.2%。
要点
- 199株尿路感染大肠埃希菌中8个谱系占56.7%,包括ST73、ST12、ST69、ST131等。
- 初筛判定6.5%的菌株为多重耐药(MDR)。
- 医院来源菌株对氨苄西林耐药率52.1%,对甲氧苄啶耐药率36.2%。
核心结论
- 诺福克报告的尿路感染负担主要由非多重耐药菌株引起,与国内外同类尿路致病性大肠埃希菌研究结果相似。
- 持续监测样本并考虑来源有助于减少疾病负担。
研究设计与样本
- 研究收集2021年8月至2022年1月诺福克与诺里奇大学医院临床微生物实验室的199株致尿路感染的临床大肠埃希菌分离株,来源为社区和医院。
- 采用Illumina和MinION平台进行全基因组测序,用于硅内MLST和抗生素耐药决定簇检测。
主要发现
- 199株分离株由70个ST型组成,其中8个谱系占该种群的56.7%,分别为ST73、ST12、ST69、ST131、ST404、ST95、ST127和ST1193。
- 初次尿路感染筛查判定6.5%的分离株为多重耐药(MDR)。
- 医院来源分离株对氨苄西林耐药率为52.1%,对甲氧苄啶耐药率为36.2%。
- 多重耐药群ST131和ST1193在社区和医院环境中可能克隆扩增,携带染色体编码的blaCTX-M-15、blaOXA-1和aac(6')-Ib-cr5。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Urinary tract infections (UTIs) are a frequent cause for visits to primary care providers. In alignment globally, uropathogenic Escherichia coli (UPEC) are the main aetiological agent for UTIs in Norfolk and are increasingly difficult to treat due to multi-drug resistance. OBJECTIVES: We set out to identify which clonal groups and resistance genes are disseminating in the community and hospitals in Norfolk, the first study of its kind for UPEC in this region. METHODS: We collected 199 clinical E. coli isolates causing UTIs in the community and hospital from the Clinical Microbiology laboratory at Norfolk and Norwich University Hospital between August 2021 and January 2022. These were whole-genome sequenced using the Illumina and MinION platforms for in silico MLST and antibiotic resistance determinant detection. RESULTS: The isolates were composed of 70 STs; 8 lineages represented 56.7% of this population: ST73, ST12, ST69, ST131, ST404, ST95, ST127 and ST1193. Importantly, primary UTI screening deemed 6.5% of isolates to be multidrug resistant (MDR), with high rates of resistance to ampicillin (52.1%) and trimethoprim (36.2%) in hospitals. Of concern is the probable clonal expansion of MDR groups ST131 and ST1193 in hospitals and community settings with chromosomally encoded blaCTX-M-15, blaOXA-1 and aac(6')-Ib-cr5. CONCLUSIONS: The burden of reported UTIs in Norfolk is largely caused by non-MDR isolates and mirrors similar UPEC studies nationally and internationally. Continually monitoring samples with consideration of sources will help reduce burden of disease.
引用
- Carter C, Hutchison A, Rudder S, et al. Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK. J Antimicrob Chemother. 2023. PMID: 37358190. doi:10.1093/jac/dkad201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。